Efficacy and Neural Mechanisms of Transcranial Direct Current Stimulation Targeting the Supplementary Motor Area for the Treatment of Subacute Post-stroke Aphasia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorThe First Affiliated Hospital of Anhui Medical University

About this trial

This study aims to investigate the efficacy of transcranial direct current stimulation (tDCS) in patients with post-stroke aphasia (PSA) and to explore its potential neural mechanisms. The study will recruit PSA patients and provide them with 14 tDCS sessions over 7 days, along with speech therapy. Language Behavior Scale scores and resting-state functional MRI scans will be collected before and after the intervention. In addition, a retrospective comparison will be conducted of language function and resting-state fMRI changes in a group of PSA patients who received only speech therapy; these patients did not undergo any physical intervention but received only speech therapy. Changes in Language Behavior Scale scores and functional connectivity (FC) before and after treatment in the speech therapy-only group will be analyzed and compared with those in the tDCS intervention group.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients must be between 18 and 80 years of age

First stroke in the left hemisphere

Stroke onset within the past 12 weeks

Native Chinese speakers who were able to communicate normally prior to onset

Disqualifiers

Time since stroke onset exceeds 12 weeks

History of psychiatric or neurological disorders

History of surgery for severe head trauma, brain tumors, or brain abscesses

Severe articulation disorders

Trial design

Design model

Parallel

Treatments tested in this trial

  • transcranial direct current stimulation

    Other intervention

    As a non-invasive brain stimulation technique, tDCS offers advantages such as convenience, safety, and low cost. Its mechanism of action involves regulating neuronal activity in the brain by applying a weak direct current to the scalp.

Treatment groups

40 Participants
are divided into 2 treatment groups
Group A: tDCS groupExperimental treatment 1 intervention
Group B: The speech-language therapy groupNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Aphasia quotient (AQ)

The Aphasia Battery of Chinese (ABC) is a standardized Chinese adaptation of the Western Aphasia Battery (WAB). The Aphasia Quotient (AQ) is a composite score that reflects the overall severity of language impairment. The AQ score ranges from a minimum of 0 to a maximum of 100. Higher scores indicate better language function (i.e., less severe impairment).

Time frame
Baseline, immediately after all interventions have ended

Secondary outcomes

1

rs-fMRI

Time frame
Baseline, immediately after all interventions have ended

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.